Antibiotics
Mom is a new macrolide antibiotic which is a derivative of the 16-membered macrolide antibiotic Mdm. Jm and Em were received from Yamanouchi Pharmaceutical Co. and Upjohn Co., respectively. The procedure regarding preparation of an Mom solution suitable to the bacteriological assay system was investigated, because of the insolubility of this macrolide antibiotic. As a result, methanol was found to be the most favourable diluent for preparing a serial dilution of this antibiotic, when MIC was measured by dilution with methanol, its assay value was found to be fairly stable. Five per cent methanol in assay medium did not affect the growth of 27 clinical isolates of S. aureus (unpublished data). For the in vitro study, each antibiotic was dissolved and appropriately diluted with methanol before preparing drug plates. For the in vivo study, each antibiotic was suspended in 0.5% hydroxylpropylmethylcellulose solution by means of mortar and pestle, and the suspension was thereafter diluted to the desired concentration with the same solution. 
Test Organisms
Twelve macrolide-resistant strains, 12 inducible strains including strain #8, and 74 sensitive strains including strain #49 were used. All these strains were isolated from clinical sources in Japan. S. aureus 537 E, D, an Em-inducible strain, was stocked in Gunma University. S. aureus strain IID803 Smith was supplied by J. Y. HOMMA, Institute of Medical Science, University of Tokyo. Animals Four-to six-weeks old male ddY mice were obtained from Shizuoka Agricultural Cooperative Association for Laboratory Animals.
Susceptibility Test of Clinical S. aureus Isolates Sensitivity test agar medium (Nissui Seiyaku Co., Ltd., Tokyo) was used for the sensitivity test. Each strain was preincubated in peptone broth for 20 hours. Cultures were diluted with peptone broth to contain approximately 108 colony forming units (CFU) per ml. The plates containing the serially diluted antibiotics were inoculated with 0.005 ml of the diluted culture with a Microplanter, and incubated at 37°C for 20 hours. The minimum inhibitory concentration (MIC) was taken as the lowest concentration which allowed no bacterial growth.
Isolation of Resistant Mutants In Vitro
The strains were incubated overnight in peptone broth and a loopful of the culture was streaked on the surface of HI agar (Eiken) plates containing 2-fold dilutions of each antibiotic. After 24 hours incubation at 37°C, the colonies on plates containing the highest concentration of antibiotic were suspended in phosphate buffered saline containing 0.01 % gelatine to contain about 108 CFU/ml. The suspensions were inoculated on the next series of plates.
Induction of Resistance S. aureus strain 537 E, D was incubated in brain heart infusion (BHI) broth (Difco) for 20 hours. The culture was diluted 100 fold with 9.5 ml of fresh BHI broth and was shaken at 37°C for 2 hours. Then the drug was added to the culture to yield a final sublethal concentration (0.1 ,ug Mom/ml, or 0.05,ug Jm/ml and 0.05 ,rcg Em/ml) of antibiotic, and incubated for 1 hour. After this induction period, the culture was challenged with 10,ug Mom/ml or 10 ,ug Jm/ml or 50 ,ug Em/ml and was further incubated at 37°C. The shift in optical density was surveyed at 530 nm every 30 minutes for 5 hours. The same volume of methanol without the antibiotic was added to the control tube.
Protection Test (i) Survival Studies: Strains IID 803 Smith and #8 were cultivated for 20 hours at 37°C on HI agar plates and suspended in BHI broth to a density of 108 and 108 CFU/ml, respectively. The suspensions were mixed with 2.5 % mucin and used for intraperitoneal challenge. The challenged mice were treated by oral administration of the antibiotics at 30 minutes post-infection. These mice were observed for 6 days, and the survival rate was recorded. From the survival rates, the median effective dose (EDBO) was determined according to the formula of LITCHFIELD-WILCOXON.2)
(ii) Antibacterial Effects in the Kidney : Renal abscesses in mice were produced by intravenous challenge of strain #49. The organisms were cultivated for 20 hours at 37°C on HI agar and suspended in BHI broth to a density of 108 CFU/ml. The challenged mice were treated by oral administration of the antibiotics at 30 minutes, 6 hours and 11 hours postinfection. The kidneys from the mice sacrificed 24 hours after the staphylococcal challenge were homogenized in BM broth. Ten-fold serial dilutions of the kidney homogenates were prepared in the same broth, and 0.1 ml each dilution was spread on the surface of HI agar plates. After incubation at 37°C for 20 hours, the CFU per kidney were estimated.
Results

MIC Distribution Patterns
The MIC distribution patterns of 98 strains are shown in Fig. 2 . The patterns of Mom, Jm, and Mdm were similar. Most of the strains were inhibited by 1.56 ,ug/ml or less of Mom, Jm or Mdm.
The MIC of Em was less than 1.56 icg/ml for the majority of the strains. The percentage of resistant strains showing an MIC of more than 100 ,ug/ml against Mom, Jm, Mdm and Em was 11, 13, 13 and 19, respectively.
Comparisons of MICs between Mom and
Jm, Mom and Mdm, and Mom and Em are shown in Fig. 3 . MICs of Mom were similar to those of Jm in the majority of tested strains. Against several strains including #9, Mom was more effective than Jm (Fig. 3-a) . The majority of the strains were two-fold more susceptible to Mom than to Mdm (Fig. 3-b) . From the correlation pattern of MICs between Mom and Em, the strains could be classified into the following 3 groups : 1) strains resistant to both Mom and Em. 2) strains susceptible to Mom but resistant to Em. 3) strains susceptible to both Mom and Em (Fig. 3-c) .
Effects of the addition of various concentrations of Mom and Jm on the growth rate of strain #9 described above were investigated and the results are shown in Fig. 4 . Growth of the organisms was inhibited by 12.8 ,ug/ml of Mom at 1.5 hours after the addition of the antibiotic (Fig. 4-a) . This inhibition was not, however, observed with the same concentration of Jm (Fig. 4-b) .
Development of Resistance and Cross Resistance In Vitro
Resistance of the macrolide sensitive strain #40 to Mom and Jm developed step by step. The MICs of Mom and Jm against strain #40 were 100 icg/ml and 50 #g/ml, respectively, after the 14th transfer ( Fig. 5-a) . The MICs against strain #38 were 6.25 #g/ml in both cases after the 10th transfer (Fig. 5-b) , and the resistance of strain #58 to Mom rose rapidly, but the rise could not be observed until the 4th transfer. After the 14th transfer, the MIC of Mom was 6.25 jug/ml. The resistance of strain #58 to Jm rose steadily, and the MIC was 50 ,ug/ml after the 14th transfer (Fig. 5-c) . Em-inducible strains were examined for development of Mom or Jm resistance. The MICs of Mom and Jm against strain 3 became more than 200 , tg/ml after the 2nd and 9th transfers, respectively ( Fig. 6-a) . The MIC of Jm against strain #S was more than 200 f#g/ml after the 2nd transfer, but Mom had antibacterial activity at 12.5 ag/ml after the 14th transfer against the same strain ( Fig. 6-e) .
The degree of resistance of strains X61, #64 and 537 E,D to Mom and Jm was similar, and after the 4th to 7th transfer, the MIC against those antibiotics was more than 200 pg/ml (Figs. 6-b, -c, -d) .
All of the 16 Mom-or Jm-resistant strains obtained in the above experiments showed complete cross resistance to both drugs ( Table 1 ).
Induction of Resistance
As shown in Figs. 7-a and -b, when the cultures were induced by 0.1 ag Mom/ml or 0.05 Eag Jm/ml and challenged by 10 #g/m1 of Mom and Jm or 50 , #g/ml of Em, the growth of S. aureus strain 537 E,D was inhibited by all three antibiotics at about 1.5 hours after the challenge, and Mom and Jm did not induce macrolide resistance. However, there was induction of resistance by Em and consequently growth of the organism was not reduced when challenged by Mom, Jm and Em (Fig. 7-c) .
The therapeutic efficacy of Mom in experimental infections in mice was compared with that of Jm and Em (Table 2) . Mom showed excellent in vivo activity against S. aureus strain including Em- Regarding the metabolism of Mom in rats, MURATA et al. 3 ) and UMEMURA et al. 4) found the rate of metabolism of Mom in vivo to be slower than that of Mdm, since two additional acetyl groups had to be deacylated.
The merit of Mom in vivo was the extraordinary high tissue levels of the metabolites which still had antibacterial activity. From these findings, further studies on Mom, including studies in man, would be worth-while. for each dose level. b) MICs were determined by the agar dilution test , using an inoculum of 108 CFU/ml.
